Otolaryngology Doctors in Tahlequah, OK Accepting Medicare

4 Otolaryngology doctors found. Showing 1 - 4

Tracey Way Childers, D.O. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1203 E Ross Byp, Suite A, Tahlequah, OK 74464 Phone: 918-453-1234    Fax: 918-453-9107

Susan K Anderson, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1203 E Ross Byp, Suite A, Tahlequah, OK 74464 Phone: 918-453-1234    Fax: 918-453-9107

Lea Sarah Humphrey, D.O. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1203 E Ross Byp, Tahlequah, OK 74464 Phone: 918-453-1234    Fax: 918-453-9107

Charles Joseph Wine, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3360    Fax: 918-458-3511

News Archive

Study shows efficacy, safety of AAV5-based gene therapy to treat sheep model of achromatopsia

A study of a large animal model of achromatopsia caused by a mutation in the CNGA3 gene that was treated with a single injection of CNGA3 gene therapy delivered using an AAV5 vector revealed findings reported long-term follow-up findings that show promise for the efficacy and safety of this therapeutic approach.

Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. has announced today that Soliris® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). AHUS is an ultra-rare, inherited, and life-threatening complement-inhibitor deficiency disease that often progresses to end-stage kidney disease or failure. The U.S. Food and Drug Administration granted orphan drug designation to Soliris for the same indication in May 2009. Soliris is not approved for the treatment of patients with aHUS.

Biotage to acquire extraction, evaporation product lines for Sample Preparation from Caliper Life Sciences

Biotage AB, a global leader in tools and technology for medicinal and analytical chemistry, and Caliper Life Sciences, Inc. today announces a transaction under which Biotage is acquiring extraction and evaporation product lines for Sample Preparation from Caliper.

Stents implanted in the coronary blood vessels may not provide extra benefit

Percutanous angioplasty involves insertion of a stent into a blocked or narrowed coronary artery that eases the blood flow and relieves the pain of severe angina or a heart attack. It is being routinely practiced worldwide. A new study called ORBITA, has revealed that not all patients who undergo this procedure benefit from it.

Read more Medical News

› Verified 7 days ago